Home › NDC Lookup › RxCUI directory › RxCUI 990982

2 ML physostigmine salicylate 1 MG/ML Injection — RxCUI 990982

RxNorm drug concept · Semantic clinical drug
RxCUI 990982 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI990982
Official name2 ML physostigmine salicylate 1 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asphysostigmine salicylate 1 MG/ML per 2 ML Injection; PHYSostigmine salicylate 1 MG/ML in 2 ML Injection
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How 2 ML physostigmine salicylate 1 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 2 ML physostigmine salicylate 1 MG/ML Injection RxCUI 990982

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Physostigmine 8299
    • Physostigmine salicylate 33656
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Physostigmine Injection 1739532
    • Physostigmine salicylate Injection 2648993
    • Physostigmine Injectable Product 1158724
    • Physostigmine salicylate Injectable Product 2661916
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Physostigmine salicylate 1 MG/ML 990981

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Physostigmine salicylate 1 MG/ML SCDC · 990981
  • Physostigmine Injection SCDF · 1739532
  • Physostigmine salicylate Injection SCDFP · 2648993
  • Physostigmine Injectable Product SCDG · 1158724
  • Physostigmine salicylate Injectable Product SCDGP · 2661916

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 990982 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
51662-1439-01 2 mL in 1 AMPULE (51662-1439-1) PHYSOSTIGMINE SALICYLATE HF Acquisition Co LLC, DBA HealthFirst 2019-12-22
51662-1439-03 10 POUCH in 1 CASE (51662-1439-3) / 1 AMPULE in 1 POUCH (51... PHYSOSTIGMINE SALICYLATE HF Acquisition Co LLC, DBA HealthFirst 2023-01-09
Observed labelers: HF Acquisition Co LLC, DBA HealthFirst (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.